Fast-Track Efforts To Produce Experimental Ebola Treatments Taking Longer Than Expected
New York Times: Fast Track on Drug for Ebola Has Faltered
“…Six months [after it was first used in two American aid workers with Ebola], very little [of the experimental drug ZMapp] has been produced, diminishing the chances that the drug can be used to treat large numbers of patients in the current outbreak, which appears to be ebbing. The delays show some gaps in preparedness and have frustrated biodefense and infectious disease experts…” (Pollack, 1/22).
The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.